Cisplatin, hyperthermia and radiation treatment in human cisplatin-sensitive and resistant glioma cell lines

References

• Amichetti M., Graiff C., Fellin G., Pani G., Boloner A., Maluta S., Valdagni R. Cisplatin hyperthermia and radiation (trimodal therapy) in patients with locally advanced head and neck tumours: a phase I—II study. Radiation Oncology 1993; 26: 801–807
   Google Scholar
• Beog A. C., van der Kolk P. J., Dewit L., Bartelink H. Radiosensitization by cisplatin of RIF1 tumour cells in vitro. International Journal of Radiation Oncology 1986; 50: 871–884
   Google Scholar
• Begg A. C., Stewart F. A., Dewit L., Bartelink H. Interactions between cisplatin and radiation in experimental rodent tumours and normal tissues. Antitumour drug-radiation interactions, B. T. Hill, A. S. Bellamy. CRC Press, Boca Raton, FL 1990; 153–170
   Google Scholar
• Ben Hur E., Elkind M. M., Bronk B. V. Thermally enhanced radioresponses of cultured Chinese hamster cells (Inhibition of repair of sublethal damage and enhance ment of lethal damage). Radiation Research 1974; 58: 38–51
   PubMed Web of Science ®Google Scholar
• Bosscha H. T., Timmer A., Meijer C., deVries E. G. E., de Jong B., Oosterhuis J. W., Mulder H. Cis-diaminedichloroplatin (II) resistance in vitro and in vivo in human embryonal carcinoma cells. Cancer Research 1993; 53: 5707–5713
   PubMedGoogle Scholar
• Bowden G. T., Kasunic M., Sim D. Sequence dependence for the hyperthermic potentiation of cis-diaminedichloroplatinum (II) induced cytotoxicity and DNA damage. Proceedings of the Third North American Hyperthermia Group. 1983; 161–162
   Google Scholar
• Britten R. A., Warenius H. M., Carraway A. V., Murray D. Differential modulation of radiosensitivity following induction of cisplatin resistance in radiation sensitive and radiation-resistant human tumour cells. Radiation Oncology Investigations 1994; 2: 25–31
   Google Scholar
• Canon J. L., Humblet Y., Symann M. Resistance to cisplatin: how to deal with the problem. European Journal of Cancer 1990; 26: 1–3
   PubMed Web of Science ®Google Scholar
• Carde P., Laval F. Effect of cis-dichlorodiamine platinum II and X-rays on mammalian cell survival. International Journal of Radiation Oncology 1981; 7: 929–933
   Google Scholar
• Coughlin C. T., Richmond R. C. Platinum based combined modality approach for locally advanced head and neck carcinoma. International Journal of Radiation Oncology 1985; 115: 915–919
   Google Scholar
• Da Silva V., Gutin P. H., Hoff M. H. B., Bernstein M. A., Deen D. F., Weaver K. A. The effect of combination treatment with cisplatin and low dose-rate 125 I radiation in a murine brachytherapy model. International Journal of Radiation Oncology 1984; 10: 1471–1472
   Google Scholar
• Da Silva V. F., Raaphorst G. P., Goyal R., Feeley M. M. Drug cytotoxicity at elevated temperature. Journal of Neurosurgery 1987; 67: 83–88
   Google Scholar
• Dewit L., Bartelink H., Rumke P. H. Concurrent cis-diaminedichloroplatinum (II) and radiation treatment for melanoma metastases: a pilot study. Radiotherapeutic Oncology 1985; 3: 303–309
   PubMed Web of Science ®Google Scholar
• Dewit L. Combined treatment of radiation and cis-diaminedichloroplatinum (II): A review of experimental and clinical data. International Journal of Radiation Oncology 1987; 13: 403–426
   Web of Science ®Google Scholar
• Dikomey E., Jung H. Correlation between polymerase β activity and thermal radiosensitization in Chinese hamster ovary cells. Recent Results in Cancer Research 1988; 109: 35–41
   PubMedGoogle Scholar
• Dikomey E., Jung H. Correlation between thermal radiosensitization and heat induced loss of DNA polymerase β activity in CHO cells. International Journal of Radiation Biology 1993; 2: 215–221
   Web of Science ®Google Scholar
• Douple E. B. Interaction between cisplatin coordination complexes and radiation. Antitumour drug-radiation interactions, B. T. Hill, A. S. Bellamy. CRC Press, Boca Raton, FL 1990; 171–190
   Google Scholar
• Douple E. B., Wills M. L., Jones E. Radiopotentiation in a murine tumour (MTG-B) by continuous infusion platinum. Concomitant Continuous infusion Chemo therapy and Radiation. Springer-Verlag, New York 1991; 191–196
   Google Scholar
• Dritschilo A., Piro A., Kelman A. D. The effect of cisplatinum on the repair of radiation damage in plateau phase Chinese hamster V79 cells. International Journal of Radiation Oncology 1979; 5: 1345–1349
   Web of Science ®Google Scholar
• Eastman A., Schulte N. Enhanced DNA repair as a mechanism of resistance to cis-diaminedichloroplatinum (II). Biochemistry 1988; 27: 4730–4734
   PubMed Web of Science ®Google Scholar
• Engelhardt R. Hyperthermia and drugs. Recent Results in Cancer Research 1987; 104: 136–203
   PubMedGoogle Scholar
• Fu K. K., Rayner P. A., Lam K. N. Modification of the effects of continuous low dose-rate irradiation by concurrent chemotherapy infusion. International Journal of Radiation Oncology 1984; 10: 1431–1478
   Google Scholar
• Fu K. K., Lam K. N., Rayner P. A. The influence of time sequence of cisplatin administration and continuous low dose-rate irradiation (LDRI) on their combined effects on murine squamous cell carcinoma. International Journal of Radiation Oncology 1985; 11: 2119–2124
   Google Scholar
• Fu K. K., Lam K. N., Rayner P. A. Effects of continuous low dose-rate irradiation and concurrent infusion of mitomycin, cisplatin and 5 Flourouracil on three murine tumours. Endocurietherapy/Hyperthermic Oncology 1986; 2: 157–162
   Google Scholar
• Fujii R., Mutak M., Niwa K., Yamada K., Aibou T., Nakagawa M., Kuwano M., Akiyama S. Active efflux for cisplatin in cisplatin-resistant human KB cells. Japanese Journal of Cancer Research 1994; 85: 426–433
   PubMedGoogle Scholar
• Proceedings of the 6th Congress on Hyperthermic Onc. (Vol. I and II). Arizona Board of Regents, Tucson, Arizona. Hahn, G. M., Potentiation of therapy drugs and hyperthermia. 1971, E. W. Gerner. 1992; 39: 2264–2268, Cancer Research
   Google Scholar
• Hall E. J. Radiobiology for the Radiologist. J. B. Lippincott, Philadelphia 1994; 107–132
   Google Scholar
• Herman T. S., Sweets C. C., White D. M., Gerner E. W. Effect of rate of heating on lethality due to hyperthermia and selected chemotherapy drugs. Journal of the National Cancer Institute 1982; 68: 487–492
   PubMedGoogle Scholar
• Herman T. S., Teicher B. A. Sequencing of trimodality therapy, (cisdiaminedi chloroplatinum/hyperthermia/radiation) as determined by tumour growth delay and tumour cell survival in the FSa II C fibrosarcoma. Cancer Research 1988; 48: 2693–2697
   PubMed Web of Science ®Google Scholar
• Ireland C. M., Pittman S. M., Jones S. L., Harnett P. R. Establishment of an in vitro model for cisplatin resistance in human neuroblastoma cell lines. Anticancer Research 1994; 14: 2397–2404
   PubMedGoogle Scholar
• Jekunen A. P., Hom D. K., Alcaraz J. E., Eastman A., Howell S. B. Cellular pharmacology of dichloro(ethylenediamine) platin II in cisplatin-sensitive and resistant human ovarian carcinoma cells. Cancer Research 1994; 54: 2680–2687
   PubMedGoogle Scholar
• Jorritsma J. B. M., Burgman P., Kampinga H. H., Konings A. W. T. DNA polymerase activity in heat killing and hyperthermic radiosensitization of mammalian cells as observed after fractionated heat treatments. Radiation Research 1986; 105: 307–319
   PubMed Web of Science ®Google Scholar
• Konings A. W. T., Hettinga J. V. E., Lemstra W., Humphrey G. B., Kapinga H. H. Sensitizing for cisplatin action by hyperthermia in resistant cells. International Journal of Hyperthermia 1993; 9: 553–562
   PubMed Web of Science ®Google Scholar
• Kubota N., Kakehi M., Inada T. Hyperthermic enhancement of cell killing by five platinum complexes in human malignant melanoma cells grown as monolayer cultures and multicellular spheroids. International Journal of Radiation Oncology 1993; 25: 491–497
   Google Scholar
• Kuske R. R., Perez C. A., Grigsby P. W., Lovett R. D., Jacobs A. J., Galakatos A. E., Camel H. M., Kao M. S. Phase I/II study of definitive radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) for advanced or recurrent gynecologic malignancies. American Journal of Clinical Oncology 1989; 12: 467–473
   PubMedGoogle Scholar
• Li G. C., Evans R. G., Hahn G. M. Modification and inhibition of repair of potentially-lethal X-ray damage by hyperthermia. Radiation Research 1976; 67: 491–501
   PubMed Web of Science ®Google Scholar
• Masuda H., Ozols R. F., Lai G. M., Fojo A., Rothenberg M., Hamilton T. C. Increased DNA repair as a mechanism of acquired resistance to cis-diaminedichlor oplatinum II in human ovarian cancer cell lines. Cancer Research 1988; 48: 5713–5716
   PubMed Web of Science ®Google Scholar
• Meijer C., Mulder N. H., Hospers G. A. P., Uges D. R. A., de Vries E. G. E. The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line. British Journal of Cancer 1990; 62: 72–77
   PubMed Web of Science ®Google Scholar
• Micetich K., Zwelling L., Kohn K. W. Quenching of DNA: platinum (II) mono adducts as a possible mechanism of resistance to cis-diaminedichloroplatinum (II) in L1210 cells. Cancer Research 1983; 43: 3609–3613
   PubMedGoogle Scholar
• Mivechi N., Dewey W. C. Effect of glycerol and low pH on heat-induced cell killing and loss of cellular DNA polymerase activities in Chinese hamster ovary cells. Radiation Research 1984; 99: 352–362
   PubMed Web of Science ®Google Scholar
• Miyahara T., Ueda K., Akaboshi M., Shimada Y., Imamura M., Utsumi H. Hyperthermic enhancement of cytotoxicity and increased uptake of cis-diaminedichloroplatinum (II) in cultured human esophageal cancer cells. Japan Journal of Cancer Research 1993; 84: 336–346
   PubMedGoogle Scholar
• Nias A. H. W. Radiation and platinum drug interaction. International Journal of Radiation Biology 1985; 48: 297–314
   Web of Science ®Google Scholar
• Oshita F., Fujiwara Y., Saigo N. Radiation sensitivities in various anticancer drug resistant human lung cancer cell lines and mechanism of radiation cross-resistance in a cisplatin-resistant cell line. Journal of Cancer Research & Clinical Oncology 1992; 119: 28–34
   PubMed Web of Science ®Google Scholar
• Piver M. S. Ovarian carcinoma, a decade of progress. Cancer 1984; 54: 2706–2715
   PubMedGoogle Scholar
• Raaphorst G. P., Freeman M. L., Dewey W. C. Radiosensitivity and recovery from radiation damage in cultured CHO cells exposed to hyperthermia at 42.5 and 45.5°C. Radiation Research 1979; 79: 390–402
   PubMed Web of Science ®Google Scholar
• Raaphorst G. P. Thermal radiosensitization in vitro. Hyperthermia and Oncology, M. Urano, E. Douple. VSP, Utrecht 1989; Vol. 2: 17–51
   Google Scholar
• Raaphorst G. P. Recovery of sublethal radiation damage and its inhibition by hyperthermia in normal and transformed mouse cells. International Journal of Radiation Oncology 1992; 22: 1035–1041
   Web of Science ®Google Scholar
• Raaphorst G. P., Feeley G. P. M. M., Chu G. L., Dewey W. C. A comparison of hyperthermia enhancement of radiation sensitivity and DNA polymerase inactivation in human glioma cells. Radiation Research 1993a; 137: 338–345
   Google Scholar
• Raaphorst G. P., Mao J. P., Ng C. E. Repair of potentially-lethal damage: its inhibition by hyperthermia in two melanoma cell lines with different radio-and heat sensitivities. Melanoma Research 1993b; 3: 351–356
   PubMed Web of Science ®Google Scholar
• Raaphorst G. P., Bussey A., Heller D. P., Ng C. E. Comparison of thermoradiosensitization in two human melanoma cell lines and one fibroblast cell line by concurrent mild hyperthermia and low-dose-rate irradiation. Radiation Research 1994a; 137: 338–345
   PubMed Web of Science ®Google Scholar
• Raaphorst G. P., Mao G. P. J. P., Ng C. E. Sublethal radiation damage repair and its inhibition by hyperthermia in two human melanoma cell lines of different radiosensitivity. Melanoma Research 1994b; 4: 157–161
   PubMed Web of Science ®Google Scholar
• Raaphorst G. P., Doja S., Davis L., Stewart D., Ng C. E. Comparison of cisplatin-hyperthermia sensitization in human ovarian carcinoma and glioma cell lines sensitive and resistant to cisplatin treatment. Cancer Chemother Pharmacology 1995a; 37: 574–580
   Google Scholar
• Raaphorst G. P., Wang G., Ng C. E. Radiosensitization by cisplatin treatment in cisplatin-resistant and sensitive human ovarian carcinoma cell lines. International Journal of Oncology 1995b; 7: 325–330
   PubMedGoogle Scholar
• Raaphorst G. P., Yang D. P., Grewaal D., Stewart D., Goel R., Ng C. E. Analysis of mechanisms of cisplatin resistance in three pairs of human tumour cell lines expressing normal and resistant responses to cisplatin. Oncology Reports 1995c; 2: 1037–1043
   PubMedGoogle Scholar
• Raaphorst G. P., Wang G., Stewart D. J., Ng C. E. Concomitant low dose-rate irradiation and cisplatin treatment in ovarian carcinoma cell lines sensitive and resistant to cisplatin treatment. International Journal of Radiation Biology 1996, (in press)
   Google Scholar
• Raaphorst G. P., Feeley M. M. Comparison of post hyperthermia radiosensitivity for survival, PLDR and polymerase activity in human glioma cells. International Journal of Radiation Oncology 1994; 29: 133–139
   Web of Science ®Google Scholar
• Schwachofer J. H. M., Crooijmans R. P. M. A., Hoogenhout J., Kal H. B., Theeuwes A. G. M. Effectiveness in inhibition of recovery of cell survival by cisplatin and carboplatin influence of treatment sequence. International Journal of Radiation Oncology 1991; 20: 1235–1241
   Google Scholar
• Sledge G. W. Cisplatin and platinum analogues in breast cancer. Seminars in Oncology 1992; 19: 78–82
   PubMedGoogle Scholar
• Supi G., Badaracco G., Cavatiere R., Natali F. G., Gerco C. Influence of sequence on hyperthermia and drug combination. Hyperthermic Oncology 1994; 1: 429–431
   Google Scholar
• Szumiel I., Nias A. H. W. The effect of combined treatment with a platinum complex and ionizing radiation of Chinese hamster ovary cells in vitro. British Journal of Cancer 1976; 33: 450–458
   PubMed Web of Science ®Google Scholar
• Taylor S. G., Murphy A. K., Vannetzel J. M., Colin P., Droy M., Calderelli D. D., Sholt S., Vokes E., Showel J. L., Huchison J. C., Witt T. R., Griem K. L., Hartsell W. F., Kies M. S., Mittal B., Rebischung J. L., Coupez D. J., Desphieux J. L., Robin J. L. S., LePajolec C. Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. Journal of Clinical Oncology 1994; 12: 385–395
   PubMed Web of Science ®Google Scholar
• Urano M., Kahn J., Kenton L. A. The effect of cisplatin I treatment at elevated temperatures on murine fibrosarcoma. F.Sa-II. International Journal of Hyperthermia 1990; 6: 563–570
   PubMed Web of Science ®Google Scholar
• Wallner K. E., Li G. C. Effect of cisplatin resistance on cellular radiation response. International Journal of Radiation Oncology 1987; 13: 587–591
   Google Scholar
• Walter P., Korbelik M., Spadinger I., Skov K. Investigations into mechanisms of the interaction between platinum complexes and irradiation at low (2 Gy) doses in hypoxic cells: role of single strand breaks. Radiation Oncology Investigations 1993; 1: 137–147
   Google Scholar
• Wang Z., Armour E. P., Corry P. M., Martinez A. Elimination of dose-rate effects by mild hyperthermia. International Journal of Radiation Oncology, Biology and Physics 1992; 24: 965–973
   PubMed Web of Science ®Google Scholar
• Wilkins D. E., Ng C. E., Raaphorst G. P. Cisplatin and low dose-rate irradiation in cisplatin-resistant and sensitive human glioma cells. International Journal of Radiation Oncology 1996, (in press)
   Google Scholar
• Wondergem J., Siddik Z. H., Strebel F. R., Bull J. M. C. Effect of whole body hyperthermia on cis-diaminedichloroplatinum (II)-induced antitumour activity and tissue Pt-distribution. Do anaesthetics influence the therapeutic ratio. European Journal of Cancer 1993; 29a: 549–554
   PubMed Web of Science ®Google Scholar
• Zietman A. L., Shipley W. U., Kaufman D. S. The combination of cisplatin based chemotherapy and radiation in the treatment of muscle-invading transitional cell cancer of the bladder. International Journal of Radiation Oncology 1993; 27: 161–170
   Google Scholar